已收盤 06-20 16:00:00 美东时间
0.000
0.00%
Artivion Reports Strong Survival and Low Morbidity in NEXUS TRIOMPHE and AMDS PERSEVERE Trials Artivion Inc. has announced the presentation of new clinical data from two trials—the NEXUS TRIOMPHE IDE trial and the AMDS PERSEVERE IDE trial—at the 62nd Annual Meeting of the Society of Thoracic Surgeon
02-02 21:01
BRIEF-RTX’s Raytheon awards TTM Technologies a multi-year contract for LTAMDS radar components for $200 million Jan 28 (Reuters) - TTM Technologies Inc TTMI.O : RTX’S RAYTHEON AWARDS TTM TECHNOLOGIES A MULTI-YEAR CONTRACT FOR LTAMDS RADAR COMPONENTS WITH A POTENTIAL VALUE OF $200 MILLION TTM TECHNOL
01-29 05:12
TTM Technologies Secures $200 Million Multi-Year Contract From Raytheon for LTAMDS Radar Components TTM Technologies Inc. has announced a multi-year agreement with Raytheon, an RTX business, to supply radio frequency assemblies, electronic hardware, and printed circuit boards for Raytheon's Lower Ti
01-29 05:01
新一代AI芯片获市场看好!2倍做多AMD隔夜涨近18%;比特币突破107000美元大关,2倍做多Coinbase ETF升超15%>>
2025-06-17 17:06
Interim Data Demonstrate Meaningful Reduction of All-Cause Mortality with AMDS
2023-10-06 04:10